» Authors » Pang-Ning Teng

Pang-Ning Teng

Explore the profile of Pang-Ning Teng including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 2162
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bateman N, Abulez T, Soltis A, McPherson A, Choi S, Garsed D, et al.
NPJ Precis Oncol . 2024 May; 8(1):97. PMID: 38710993
No abstract available.
2.
Bateman N, Abulez T, Soltis A, McPherson A, Choi S, Garsed D, et al.
NPJ Precis Oncol . 2024 Mar; 8(1):68. PMID: 38480868
We performed a deep proteogenomic analysis of bulk tumor and laser microdissection enriched tumor cell populations from high-grade serous ovarian cancer (HGSOC) tissue specimens spanning a broad spectrum of purity....
3.
Teng P, Schaaf J, Abulez T, Hood B, Wilson K, Litzi T, et al.
iScience . 2024 Mar; 27(3):109198. PMID: 38439970
Numerous multi-omic investigations of cancer tissue have documented varying and poor pairwise transcript:protein quantitative correlations, and most deconvolution tools aiming to predict cell type proportions (cell admixture) have been developed...
4.
Hunt A, Bateman N, Barakat W, Makohon-Moore S, Abulez T, Driscoll J, et al.
Clin Proteomics . 2024 Jan; 21(1):4. PMID: 38254014
Background: Although uterine serous carcinoma (USC) represents a small proportion of all uterine cancer cases, patients with this aggressive subtype typically have high rates of chemotherapy resistance and disease recurrence...
5.
Teng P, Barakat W, Tran S, Tran Z, Bateman N, Conrads K, et al.
Transl Psychiatry . 2023 Oct; 13(1):318. PMID: 37833300
Alcohol use disorder (AUD) affects transcriptomic, epigenetic and proteomic expression in several organs, including the brain. There has not been a comprehensive analysis of altered protein abundance focusing on the...
6.
Ao W, Kim H, Tommarello D, Conrads K, Hood B, Litzi T, et al.
Gynecol Oncol . 2023 Aug; 177:60-71. PMID: 37639904
Objective: ATR kinase inhibitors promote cell killing by inducing replication stress and through potentiation of genotoxic agents in gynecologic cancer cells. To explore mechanisms of acquired resistance to ATRi in...
7.
Bateman N, Tarney C, Abulez T, Hood B, Conrads K, Zhou M, et al.
iScience . 2022 Jan; 25(1):103665. PMID: 35036865
Characterization of ancestry-linked peptide variants in disease-relevant patient tissues represents a foundational step to connect patient ancestry with disease pathogenesis. Nonsynonymous single-nucleotide polymorphisms encoding missense substitutions within tryptic peptides exhibiting...
8.
Bateman N, Teng P, Hope E, Hood B, Oliver J, Ao W, et al.
Cancer Med . 2019 Dec; 9(3):1092-1103. PMID: 31808620
Preoperative use of metformin in obese women with endometrioid endometrial cancer (EEC) reduces tumor proliferation and inhibits the mammalian target of rapamycin pathway, though is only effective in select cases....
9.
Teng P, Bateman N, Wang G, Litzi T, Blanton B, Hood B, et al.
Hum Cell . 2017 Mar; 30(3):226-236. PMID: 28251557
High grade serous ovarian cancer (HGSOC) patients have a high recurrence rate after surgery and adjuvant chemotherapy due to inherent or acquired drug resistance. Cell lines derived from HGSOC tumors...
10.
Phippen N, Bateman N, Wang G, Conrads K, Ao W, Teng P, et al.
Front Oncol . 2016 Nov; 6:213. PMID: 27833898
Background And Objective: Nua kinase 1 (NUAK1) was identified in multigene signatures of survival and suboptimal debulking in high-grade serous ovarian cancer (HGSOC). This study investigates the individual clinical and...